Canary Capital Aims to Launch First-Ever Staked Injective ETF – Wall Street’s Next Crypto Gamble?

Move over, Bitcoin ETFs—Canary Capital just upped the ante. The investment firm is pushing regulators to greenlight the first staked Injective (INJ) ETF in the US, a move that could force traditional finance to finally take DeFi yields seriously.

Why This Matters

Staking rewards meet SEC scrutiny. If approved, this ETF wouldn’t just track INJ’s price—it’d passively generate yield by participating in blockchain validation. Translation: Wall Street might actually have to learn how proof-of-stake works.

The Fine Print

No filing details yet, but the proposal likely mirrors crypto-native staking strategies while wrapping them in a 401(k)-friendly package. Expect the usual regulatory theater—unless the SEC wants to explain why a 5% APY is 'too risky' while 0.01% savings accounts get a pass.

Bottom Line

Another test for crypto’s institutional adoption. Whether it flies or crashes, the real winner is Injective—getting ETF attention puts it in the big leagues. Just don’t expect your financial advisor to understand how it works.

TLDR

• Canary Files First Staked Injective ETF, Blending Yield with Regulation

• INJ ETF by Canary Offers 10%+ Staking Yields in Regulated Format

• Canary Launches Staked INJ ETF Amid Push for Crypto Clarity Laws

• New Injective ETF Bridges DeFi Yields with Traditional Finance

• Staked INJ ETF Debuts, Marrying Crypto Rewards with SEC Compliance

Canary Capital has officially filed with the SEC for the first-ever staked Injective ETF in the US. This proposed fund will combine exposure to the Injective token with staking rewards, creating a new format for regulated yield. The launch positions Canary Capital as a key player as the regulatory environment adapts to crypto-based financial products.

The staked Injective ETF will hold INJ and actively stake it on the Injective proof-of-stake network. This model allows the fund to generate annual staking rewards of approximately 10% to 12%. These rewards will be passed directly to shareholders, adding a second LAYER of returns beyond token performance.

1/ History is being made today!

Canary Capital just filed the first US Staked $INJ ETF with the SEC, giving institutions and everyday investors a regulated path to access the native Injective token through traditional brokerages and banking rails.

Here's why it's a big deal 🧵 pic.twitter.com/GkLtkR41N1

— Injective 🥷 (@injective) July 17, 2025

The ETF aims to simplify access to staking for traditional market participants through a regulated vehicle. By doing so, it reduces the technical and custodial barriers often associated with direct staking. It also promotes broader access to decentralized finance without compromising regulatory compliance.

Canary Capital structured the ETF under a Delaware statutory trust, aligning with SEC expectations. This structure supports clarity in validator selection, custodianship, and the treatment of staking yield. The filing reflects confidence in the evolving U.S. stance on staking-based digital asset products.

The filing arrives during crypto Week 2025, when Congress is considering the CLARITY Act and related legislation. The bill aims to define whether tokens are securities or commodities, setting clearer roles for the SEC and CFTC. This timing boosts Canary’s chances of navigating the regulatory process with improved clarity.

U.S. regulators have recently signaled openness to staking-based ETFs under structured frameworks. Canary’s filing follows the successful launch of a solana staking ETF, indicating increased demand for regulated yield-generating funds. Canary appears to be leveraging this momentum as it expands its digital asset ETF portfolio.

If passed, the CLARITY Act will guide token classification and investor protection frameworks. This will support compliance for blockchain-based funds such as the Injective ETF. The proposal could become the foundation for more staking-integrated ETFs in the future.

Injective’s network has gained traction through strategic partnerships with firms like Google Cloud, T-Mobile, and BitGo. These collaborations enhance the platform’s credibility and support the technical infrastructure required for staking operations. Canary’s ETF filing builds on this momentum by adding regulated financial access to the network’s native token.

The Injective blockchain powers decentralized applications and its token, INJ, supports network consensus via staking. The ETF’s design enables secure exposure to this yield mechanism within a traditional investment wrapper. This creates a new bridge between institutional finance and decentralized systems.

Canary Capital continues to position itself at the forefront of digital asset integration. It has also filed for ETFs tied to XRP, Solana and Hedera, among others. The Injective ETF strengthens its broader strategy of embedding staking into compliant investment offerings.

This staked Injective ETF filing introduces a new model for regulated, yield-bearing crypto exposure in the United States.